|4Apr 2, 4:48 PM ET

CESCA THERAPEUTICS INC. 4

4 · CESCA THERAPEUTICS INC. · Filed Apr 2, 2015

Insider Transaction Report

Form 4
Period: 2015-03-31
Transactions
  • Award

    Common Stock

    2015-03-31$0.90/sh+9,722$8,7509,722 total
Footnotes (1)
  • [F1]As Chairman of the Clinical Program Review Committee, the reporting person receives common stock in lieu of cash for 50% of the committee fees.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4